Pranit Pathak ☆ 2009-08-19 16:44 (5149 d 09:39 ago) Posting: # 4062 Views: 3,303 |
|
Dear All, If sponsor receive letter from CRO regarding the biological sample disposition after the retention period has been completed, and sponsor still not submitted concerned data to any regulatory body. What will be the solution? If sample discarded, then what will be the regulatory issue? Edit: Category changed; see also this post #1. [Helmut] — Mumbai, India. |
Helmut ★★★ ![]() ![]() Vienna, Austria, 2009-08-19 17:24 (5149 d 09:00 ago) @ Pranit Pathak Posting: # 4063 Views: 2,807 |
|
Dear Pranit! Hopefully the CRO has an SOP for the storage and destruction of biosamples in place. Generally the length of storage period after submission of the final analytical report should be part of the contract between sponsor and CRO. When I was in a CRO our procedures were as following:
❝ If sample discarded, then what will be the regulatory issue? No idea. Maybe you take a photograph of the sample set? Include a digital watermark to prevent manipulation of the image. ![]() — Dif-tor heh smusma 🖖🏼 Довге життя Україна! ![]() Helmut Schütz ![]() The quality of responses received is directly proportional to the quality of the question asked. 🚮 Science Quotes |
Ohlbe ★★★ France, 2009-08-31 01:47 (5138 d 00:36 ago) @ Pranit Pathak Posting: # 4136 Views: 2,832 |
|
Dear Pranit, ❝ If sample discarded, then what will be the regulatory issue? As far as I know: none. I am not aware of any requirement in any of the main BE guidelines (EU, USA, WHO...) requiring the plasma samples to be kept for any period of time once the trial is completed. The main possible issue is if the re-analysis of the samples is needed once the list of questions is received from the authorities (if they want another analyte, or if problems are identified with the bioanalytical method used). But then you won't have sufficient long-term stability data anyway. As Helmut says in his answer: make sure the retention period is specified in the contract. Regards Ohlbe |